(BUSINESS WIRE)--MabSpace Biosciences Co., Ltd announced today that it has signed a collaborative contract of a novel therapeutic antibody with Genor Biopharma Co. Ltd (GenorBio), the mAb division of Walvax Group, one of the leading therapeutic antibody development companies in China.

(BUSINESS WIRE)--MabSpace Biosciences Co., Ltd. announced today that it has signed a collaborative contract with Jiangsu Hengrui Medicine Co., Ltd, one of the leading innovative pharmaceutical companies in China, to co-develop novel antibody therapeutics on two targets.

(BUSINESS WIRE)--MabSpace Biosciences Co., Ltd announced today that it has signed a collaborative contract of a novel therapeutic antibody with Genor Biopharma Co. Ltd (GenorBio), the mAb division of Walvax Group, one of the leading therapeutic antibody development companies in China.

(BUSINESS WIRE)--MabSpace Biosciences Co., Ltd. announced today that it has signed a collaborative contract with Jiangsu Hengrui Medicine Co., Ltd, one of the leading innovative pharmaceutical companies in China, to co-develop novel antibody therapeutics on two targets.